Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NVAX |
---|---|---|
09:32 ET | 464282 | 14.57 |
09:34 ET | 263009 | 14.5157 |
09:36 ET | 186571 | 14.32 |
09:38 ET | 223926 | 14.21 |
09:39 ET | 218012 | 14.2401 |
09:41 ET | 189554 | 14.36 |
09:43 ET | 107353 | 14.27 |
09:45 ET | 81936 | 14.2425 |
09:48 ET | 134563 | 14.0424 |
09:50 ET | 100894 | 14.015 |
09:52 ET | 172251 | 13.984 |
09:54 ET | 189142 | 14.03 |
09:56 ET | 49069 | 13.98 |
09:57 ET | 99841 | 13.91 |
09:59 ET | 117508 | 13.9499 |
10:01 ET | 270085 | 13.7743 |
10:03 ET | 126262 | 13.804 |
10:06 ET | 115959 | 13.7401 |
10:08 ET | 197424 | 13.7042 |
10:10 ET | 163083 | 13.6184 |
10:12 ET | 270537 | 13.5799 |
10:14 ET | 134714 | 13.54 |
10:15 ET | 199311 | 13.5495 |
10:17 ET | 169143 | 13.648 |
10:19 ET | 95522 | 13.675 |
10:21 ET | 161893 | 13.7389 |
10:24 ET | 130840 | 13.76 |
10:26 ET | 95712 | 13.725 |
10:28 ET | 57035 | 13.735 |
10:30 ET | 54270 | 13.66 |
10:32 ET | 92460 | 13.645 |
10:33 ET | 76837 | 13.601 |
10:35 ET | 41015 | 13.625 |
10:37 ET | 52013 | 13.6801 |
10:39 ET | 25752 | 13.635 |
10:42 ET | 70545 | 13.5897 |
10:44 ET | 38044 | 13.605 |
10:46 ET | 65381 | 13.66 |
10:48 ET | 41502 | 13.6804 |
10:50 ET | 72452 | 13.67 |
10:51 ET | 40874 | 13.6495 |
10:53 ET | 37513 | 13.6753 |
10:55 ET | 54195 | 13.65 |
10:57 ET | 32722 | 13.63 |
11:00 ET | 73324 | 13.73 |
11:02 ET | 91193 | 13.7264 |
11:04 ET | 69452 | 13.61 |
11:06 ET | 64211 | 13.65 |
11:08 ET | 53190 | 13.62 |
11:09 ET | 17179 | 13.585 |
11:11 ET | 62304 | 13.6623 |
11:13 ET | 114966 | 13.825 |
11:15 ET | 126406 | 13.8495 |
11:18 ET | 70167 | 13.811 |
11:20 ET | 62766 | 13.807 |
11:22 ET | 60047 | 13.88 |
11:24 ET | 394538 | 13.8895 |
11:26 ET | 287270 | 14.06 |
11:27 ET | 149882 | 14.065 |
11:29 ET | 66492 | 14.02 |
11:31 ET | 78104 | 14.14 |
11:33 ET | 83514 | 14.0998 |
11:36 ET | 55079 | 14.05 |
11:38 ET | 31713 | 14.025 |
11:40 ET | 59459 | 13.945 |
11:42 ET | 69578 | 14 |
11:44 ET | 91023 | 14.1751 |
11:45 ET | 41209 | 14.1716 |
11:47 ET | 80850 | 14.0949 |
11:49 ET | 28302 | 14.11 |
11:51 ET | 43979 | 14.1745 |
11:54 ET | 76512 | 14.125 |
11:56 ET | 37142 | 14.05 |
11:58 ET | 38425 | 14.04 |
12:00 ET | 72164 | 14.105 |
12:02 ET | 32473 | 14.08 |
12:03 ET | 70786 | 13.96 |
12:05 ET | 77604 | 13.9795 |
12:07 ET | 42308 | 14.14 |
12:09 ET | 43222 | 14.16 |
12:12 ET | 95921 | 14.17 |
12:14 ET | 48824 | 14.2276 |
12:16 ET | 56862 | 14.215 |
12:18 ET | 55324 | 14.21 |
12:20 ET | 60470 | 14.12 |
12:21 ET | 23134 | 14.15 |
12:23 ET | 26091 | 14.15 |
12:25 ET | 34764 | 14.1201 |
12:27 ET | 48274 | 14.05 |
12:30 ET | 88278 | 14.01 |
12:32 ET | 48215 | 14.065 |
12:34 ET | 29717 | 14.1 |
12:36 ET | 50296 | 14.055 |
12:38 ET | 15296 | 14.07 |
12:39 ET | 26695 | 14.16 |
12:41 ET | 16427 | 14.185 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Novavax Inc | 2.2B | -4.5x | --- |
PTC Therapeutics Inc | 2.9B | -4.7x | --- |
ACADIA Pharmaceuticals Inc | 2.5B | -1,153.8x | --- |
Azenta Inc | 3.0B | -19.5x | --- |
P3 Health Partners Inc | 201.1M | -1.1x | --- |
Beam Therapeutics Inc | 2.1B | -14.3x | --- |
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
---|---|
Revenue (TTM) | $996.6M |
Shares Outstanding | 140.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.01 |
EPS | $-3.18 |
Book Value | $-5.14 |
P/E Ratio | -4.5x |
Price/Sales (TTM) | 2.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -39.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.